UBE2NL and ovarian cancer: Together, the identification of UBE2NL and HIST2H3PS2 in EXs derived from aggressive ovarian cancer cells provides new insights into the molecular underpinnings of gynecologic cancer progression and highlights their potential as prognostic biomarkers and therapeutic targets.